Chinese english Germany Japanese Korea

Fmoc-D-Leu-Ome

Fmoc-D-Leu-Ome Struktur
172846-55-8
CAS-Nr.
172846-55-8
Englisch Name:
Fmoc-D-Leu-Ome
Synonyma:
Fmoc-D-Leu-Ome;D-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, methyl ester;methyl (2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-methylpentanoate
CBNumber:
CB14858181
Summenformel:
C22H25NO4
Molgewicht:
367.44
MOL-Datei:
172846-55-8.mol
Request For Quotation

Fmoc-D-Leu-Ome Eigenschaften

Siedepunkt:
522.0±33.0 °C(Predicted)
Dichte
1.155±0.06 g/cm3(Predicted)
pka
10.58±0.46(Predicted)

Sicherheit

Fmoc-D-Leu-Ome Chemische Eigenschaften,Einsatz,Produktion Methoden

Fmoc-D-Leu-Ome Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Fmoc-D-Leu-Ome Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
GL Biochem(Binhai) Ltd. 		+86-021-61263370 +8615301650015
 wuqiuyan@glschina.com China 2975 58
BOC Sciences 		+16314854226
 inquiry@bocsci.com United States 19743 58
Wuxi Asia Peptide Biotechnology Limited Company 0510-83583050 13771062561
 willsun@peptide-search.com China 6716 58
Kanghua (Shanghai) New Drug Development Co., Ltd. 021-61263370 18901917034
 xingli@glbiochem.com China 5637 58
Shanghai Jifeng Biotechnology Co., Ltd. 021-61263377 15023907684
 15800684150@163.com China 8131 58
Binhai gill polypeptide co. LTD 021-61263389 13524856427
 Joetang@glschina.com China 9618 58
Shanghai Anhua Biotechnology Co., Ltd. 021-61263375 18168859245
 China 5958 58
Wuxi maimo topp biotechnology co., LTD 15861600115
 lisa-li@mimotopes.cn China 5853 58
Jiangsu Shengkang Meixiang Technology Co., Ltd. 18217475093
 1615396342@qq.com China 4309 58
Gill polypeptide biopharmaceutical (dalian) co., LTD 021-61263455 13167021076
 amy@glschina.com China 8217 58
  • Fmoc-D-Leu-Ome
  • D-Leucine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, methyl ester
  • methyl (2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-4-methylpentanoate
  • 172846-55-8
Copyright 2019 © ChemicalBook. All rights reserved